Results

Total Results: 272 records

Showing results for "end stage renal".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
    August 27, 2012 - Before we begin I would like to set the stage for why we felt this was an important webcast to host. … minutes at the end. … I will be discussing the use of analytic hierarchy process, the stage of which was set very nicely … The gain for going from five months to ten months in progression free survival in renal cell carcinoma … specific question for you, Reed, is how do you manage to get patient input on things like treatment for renal
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
    October 01, 2015 - were no clear differences between fluorescent cystoscopy and white light cystoscopy in the risk of renal … tumor stage. … Fluorescent vs. white light cystoscopy: renal and genitourinary adverse events Low There were no … clear differences between fluorescent cystoscopy and white light cystoscopy in risk of renal and genitourinary … Surveillance, Epidemiology and End Results Program: Turning Cancer Data Into Discovery.
  3. effectivehealthcare-admin.ahrq.gov/products/predictors-trauma-care/research-protocol
    December 01, 2019 - several additional factors such as age, prior conditions (e.g., anticoagulation and bleeding disorders, end-stagerenal disease, pregnancy >20 weeks), burns with or without trauma, and EMS judgement and recommends … The end points or "outcomes" of interest are the predictive utility of the measures. … ("tissue oxygen saturation" or "end-tidal" or "lactate").mp. … ("tissue oxygen saturation" or "end-tidal" or "lactate").mp.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - aminotransferase [AST], alanine aminotransferase [ALT], alkaline phosphatase [ALP], or hepatitis) o Renal … disease, with known cardiovascular disease; participants with diabetes; participants with hepatic or renal … dysfunction or end-stage renal disease; participants taking a cardiovascular drug for an indication … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_disposition-comments.pdf
    June 30, 2015 - included was carboplatin/gemcitabine as chemotherapy. while this is commonly used for those with renal … compared to no or limited PLND Q3b – SWOG 8710 did report a significant benefit when risk stratified by stage … SWOG 8710 (Grossman et al) found no interaction between tumor stage and effects of treatment, as … Between 1/2014 and the end of 2015 there has been and will be more new data now with respect to biomarkers
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
    September 01, 2012 - o Studies of only patients with disease reflects the extreme end of the spectrum of disease severity … o Studies of only patients with disease reflects the extreme end of the spectrum of disease severity … Serum free light chain measurements move to center stage. … Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high … Failure Due to Myeloma Cast Nephropathy Recruiting Chronic renal failure with uremic nephropathy
  7. effectivehealthcare-admin.ahrq.gov/products/venous-ulcers-treatment/research-protocol
    December 01, 2019 - antibiotics (KQ 2) Allergic and hypersensitivity reactions Drug toxicity (not allergic) Major—renal … Key Informants Key Informants are the end-users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … daily doses Aminoglycosides Gentamicin, tobramycin, amikacin Can be dosed once daily Major renal … toxicity; requires close monitoring of dose, drug levels, renal function Table 3 Table 3
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/predictors-trauma-care_research-protocol.pdf
    May 31, 2017 - several additional factors such as age, prior conditions (e.g., anticoagulation and bleeding disorders, end-stagerenal disease, pregnancy>20 weeks), burns with or without trauma, and EMS judgement and recommends … such as complexity/variability of heart rate, tissue O2 saturation, mean arterial pressure, lactate, end-tidal … limited to respiration rate, tissue O2 saturation, respiratory effort, measure of acidemia (e.g., end-tidal … The end points or “outcomes” of interest are the predictive utility of the measures.
  9. effectivehealthcare-admin.ahrq.gov/products/medication-therapy-management/research-protocol
    December 01, 2019 - 2013, this criterion includes at least five of nine core chronic conditions—Alzheimer’s disease and end-stagerenal disease were the added conditions. … Because of the stage of the science in this area, we anticipate that the benefit from conducting a systematic … pressure; total, low-density lipoprotein, or high-density lipoprotein cholesterol; pulmonary function; renal … Because of their role as end-users, individuals are invited to serve as Key Informants, and those who
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
    November 01, 2012 - refers to the cross-linking of polyethylene glycol molecules to the interferon molecule, which delays renal … harms differ according to patient subgroup characteristics, including HCV genotype, age, race, sex, stage … performed in groups stratified by HCV genotype as well as by race, age, body weight, viral load, stage … improvement in measures related to quality of life (generic or disease-specific) 24 weeks after the end … Low bid = twice daily; CI = confidence interval; ESLD = end-stage liver disease; HCC = hepatocellular
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
    September 13, 2012 - Major—renal toxicity, hepatic toxicity, gastrointestinal upset c. … Source: www.effectivehealthcare.ahrq.gov Published Online: September 13, 2012 Key Informants are the end-users … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … multiple daily doses Aminoglycosides Gentamicin, tobramycin, amikacin Can be dosed once daily Major renal … toxicity; requires close monitoring of dose, drug levels, renal function Abbreviations: C. diff
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
    January 01, 2014 - 2013, this criterion includes at least five of nine core chronic conditions—Alzheimer’s disease and end-stagerenal disease were the added conditions. … Because of the stage of the science in this area, we anticipate that the benefit from conducting a systematic … pressure; total, low-density lipoprotein, or high-density lipoprotein cholesterol; pulmonary function; renal … Because of their role as end-users, individuals are invited to serve as Key Informants, and those who
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
    January 01, 2015 - include the microvascular complications of retinopathy and blindness, neuropathy, nephropathy, and end-stage … pressure and heart rate, and for studies that include a comparison with SGLT-2 inhibitors, impaired renal … The exclusion criteria were generally similar for most trials: significant renal, cardiovasular, and … rosiglitazone and pioglitazone, are contraindicated in patients with serious or severe heart failure (Stage … 3 or Stage 4) according to product labels.54, 55 We had low or insufficient strength of evidence for
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
    November 27, 2012 - With such a large population progressing toward end-stage liver disease we need to find these people … needlessly suffer and our healthcare system will be further overburdened and, frankly, overrun, with end-stage … screening becomes irrelevant because a substantial proportion of HCV patients will have developed end-stageStage Renal Disease. … I have seen many many hospitalized patients with end stage liver disease who are alcoholics AND have
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
    September 01, 2012 - While adherence improved, many patients still failed to receive 100% indicated treatments at the end … Health care institutions struggle with the challenge of providing excellent palliative and end-of-life … BACKGROUND: High quality end-of-life care in the community is achieved with effective multidisciplinary … BACKGROUND: Chronic renal failure and haemodialysis treatment is a long-term process; patients need … become established in partnership working; the collaborative approach to providing palliative care for end-stage
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
    April 11, 2016 - Effects"on"office"and"home"blood"pressure" of"the"lercanidipine'enalapril"combination"in"patients"with"Stage … Blood"pressure"changes"after"renal"denervation"at"10"European"expert" centers." … Abstracts"from"relevant"literature"are"included"at"the"end"of"the"attached" document." … $Abstracts$are$provided$for$included$literature$at$the$end$of$ the$document.$ Conclusions(From(Original … Usual(Care:( Clinical(Outcomes( SOE:(Insufficient( ( One$quality$C$study$reported$ on$mortality$and$end"stage
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
    April 01, 2013 - refers to the cross-linking of polyethylene glycol molecules to the interferon molecule, which delays renal … improvement in measures related to quality of life (generic or disease-specific) 24 weeks after the end … Low Note: CI=confidence interval, ESLD=end-stage liver disease, HCC=hepatocellular carcinoma, HCV=hepatitis … week 8 Alanine aminotransferase and aspartate aminotransferase normalization: in normal range at end … in relation to Interleukin 28B (IL28-b) expression Incidence of anemia Response rate (rapid/early/end
  18. Untitled (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
    December 01, 2015 - Excluded: Pregnant women, HIV co-infected, transplant recipients, patients with renal failure Interventions … Abstracts from relevant literature are included at the end of the attached document. … Abstracts are provided for included literature at the end of the document. … No trials reported harms in patients stratified by factors such as HCV genotype, age, race, sex, stage … response; RR = relative risk; HCV-RNA = hepatitis c virus-ribonucleic acid; BMI = body mass index; ESLD = end-stage
  19. Untitled (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
    December 01, 2015 - Excluded: Pregnant women, HIV co-infected, transplant recipients, patients with renal failure Interventions … Abstracts from relevant literature are included at the end of the attached document. … Abstracts are provided for included literature at the end of the document. … No trials reported harms in patients stratified by factors such as HCV genotype, age, race, sex, stage … response; RR = relative risk; HCV-RNA = hepatitis c virus-ribonucleic acid; BMI = body mass index; ESLD = end-stage
  20. effectivehealthcare-admin.ahrq.gov/products/diabetes-behavior-programs/research-protocol
    December 01, 2019 - glucose regulation; medication adherence; or self-monitoring for diabetic complications (foot, eye and renal … glucose awareness, medication adherence, or self-monitoring for diabetic complications (foot, eye, and renal … propose the following time points, but will seek input from the TEP to confirm their appropriateness: end … Key Informants Key informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as key informants and those who

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: